GT Biopharma (GTBP) had the highest return between 2009 and 2012 by a US stock in the Nasdaq Composite (IXIC), returning 1,902,936,443.8%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2009-2012	1,902,936,443.75%
NextTrip (NTRP)	2009-2012	38,566.67%
BioLineRx (BLRX)	2009-2012	24,419.07%
Pioneer Power Solutions (PPSI)	2009-2012	11,111.15%
Sleep Number (SNBR)	2009-2012	9,965.38%
Flux Power (FLUX)	2009-2012	4,900%
VerifyMe (VRME)	2009-2012	4,114.29%
Mitek Systems (MITK)	2009-2012	3,912.5%
Titan Pharmaceuticals (TTNP)	2009-2012	3,828.58%
Patrick Industries (PATK)	2009-2012	3,789.74%
Cocrystal Pharma (COCP)	2009-2012	2,995.24%
Jazz Pharmaceuticals (JAZZ)	2009-2012	2,747.59%
Avis Budget (CAR)	2009-2012	2,691.45%
Sirius XM (SIRI)	2009-2012	2,292.92%
BOS Better Online Solutions (BOSC)	2009-2012	2,155%
TriMas (TRS)	2009-2012	1,959.43%
Lululemon Athletica (LULU)	2009-2012	1,817.74%
Expedia (EXPE)	2009-2012	1,798.29%
EXACT Sciences (EXAS)	2009-2012	1,757.89%
eGain (EGAN)	2009-2012	1,700%
Altisource Portfolio Solutions (ASPS)	2009-2012	1,563.42%
Nexstar Broadcasting (NXST)	2009-2012	1,480.6%
8x8 Inc Common Stock (EGHT)	2009-2012	1,376%
Nova (NVMI)	2009-2012	1,350.91%
XTL Biopharmaceuticals Ltd ADR (XTLB)	2009-2012	1,306.65%